Christopher J. Tignanelli

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19

Carolyn T. Bramante, Jared D. Huling, Christopher J. Tignanelli et al. · New England Journal of Medicine · 2022 · 235 citations · Full text

Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

Carolyn T. Bramante, Nicholas E. Ingraham, Thomas A. Murray et al. · The Lancet Healthy Longevity · 2020 · 222 citations · Full text

Disease Risk Assessment, Global Health, Covid-19 Pandemic +7

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

Carolyn T. Bramante, John B. Buse, David Liebovitz et al. · The Lancet Infectious Diseases · 2023 · 209 citations · Full text

Disease Management, Treatment And Prevention, Post-covid-19 Condition +7

Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients

T. Andrea, Christopher J. Tignanelli, Benjamin Jacobs et al. · Journal of Vascular Surgery Venous and Lymphatic Disorders · 2018 · 182 citations

Empirical Systemic Anticoagulation, Pulmonary Embolism, Thrombosis +9

The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care

Christopher J. Tignanelli, Lena M. Napolitano · JAMA Surgery · 2018 · 182 citations